Search results - ORA - Oxford University Research Archive

« Previous | 1 - 20 of 23 | Next »

1

Thesis

Developing a framework for modelling outcomes in diabetes - A case study with ASCEND

Keng, MJ
2022

2

Conference item

N-BNP and vascular disease among 20,536 patients in the MRC/BHF Heart Protection Study

Emberson, J, Armitage, J, Ng, L, et al.
2005-09-01

3

Journal article

Aspirin for primary prevention of vascular disease in people with diabetes.

Haynes, R, Bowman, L, Armitage, J
2009-01-01

4

Journal article

Human oxygen sensing may have origins in prokaryotic elongation factor Tu prolyl-hydroxylation.

Scotti, J, Leung, I, Ge, W, et al.
2014-09-01

5

Journal article

Lipoprotein-associated phospholipase A(2) activity and mass in relation to vascular disease and nonvascular mortality

Parish, S, Offer, A, Thompson, A, et al.
2010-10-01

6

Journal article

SLCO1B1 variants and statin-induced myopathy--a genomewide study.

Link, E, Parish, S, Armitage, J, et al.
2008-08-01

7

Conference item

MRC/BHF heart protection study (HPS): Mortality, cancer incidence and major vascular events during 4 years post-trial follow-up of HPS

Bulbulia, R, Bowman, L, Wallendszus, K, et al.
2007-03-06

8

Journal article

Diabetes and impaired glucose tolerance: a review of the epidemiological and trial evidence for their role in cardiovascular risk.

Bowman, L, Armitage, J
2002-11-01

9

Journal article

No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study.

Hopewell, J, Parish, S, Clarke, R, et al.
2011-05-17

10

Conference item

Large-scale clinical trials: Reliable answers in cardiovascular medicine

Bowman, L
2006-06-01

11

Journal article

How the NHS research governance procedures could be modified to greatly strengthen clinical research.

Haynes, R, Bowman, L, Rahimi, K, et al.
2010-04-01

12

Journal article

Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20,536 high-risk people.

Armitage, J, Bowman, L, Collins, R, et al.
2009-01-01

13

Journal article

Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20,536 high-risk individuals: a randomised controlled trial.

Bulbulia, R, Bowman, L, Wallendszus, K, et al.
2011-12-01

14

Conference item

N-terminal pro-B-type natriuretic peptide and vascular disease among 20,536 patients in the MRC/BHF heart protection study

Emberson, J, Armitage, J, Ng, L, et al.
2005-10-25

15

Journal article

Clinical trials of lipid-modifying agents: design considerations

Bowman, L, Haynes, R, Armitage, J
2011-02-01

16

Journal article

Recruiting patients cost-effectively by mail.

Aung, T, Cowan, H, Haynes, R, et al.
2011-12-13

17

Journal article

How Salmonella oxidises H 2 under aerobic conditions

Parkin, A, Bowman, L, Roessler, M, et al.
2012-03-09

18

Journal article

Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): characteristics of a randomized trial among 12064 myocardial infarction survivors.

Bowman, L, Armitage, J, Bulbulia, R, et al.
2007-11-01

19

Journal article

No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study.

Hopewell, J, Parish, S, Clarke, R, et al.
2011-05-01

20

Journal article

Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.

Armitage, J, Bowman, L, Clarke, R, et al.
2010-06-01

TO TOP